Oncology
September is Gynecologic and Ovarian Cancer Awareness Month
Endometrial and ovarian cancer are among the most common gynecologic cancers in the US. This month, we reaffirm our commitment to supporting the community through education and awareness. Visit Our Way Forward for resources to help those affected by gynecologic cancers move forward with confidence.
Oncology
Our Commitment to the Blood Cancer Community
This September, we stand with the blood cancer community by raising awareness, advancing education, and supporting research that addresses the unmet needs of people living with these diseases. Together, we can help drive progress for those impacted by blood cancers.
Oncology
September is Blood Cancer Awareness Month
Explore the Mapping Myelofibrosis website for information about myelofibrosis--a rare blood cancer--including common symptoms, educational resources, and support tools for those living with the disease and their loved ones.
Behind the science US edition
Investors
We announced our second quarter 2026 results on Tuesday, 28 July.
Press releases
- Jemperli (dostarlimab-gxly) accepted for priority review by the US FDA for dMMR/MSI-H locally advanced rectal cancer
- Blenrep assigned permanent billing code, supporting timely access for patients with relapsed/refractory multiple myeloma
- Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
GSK Global links
Visit our Global site for additional features